1-4 of 4
Chiara Pautasso
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Feasibility of Dose/Schedule-Adjusted Rd-R Vs. Continuous Rd in Elderly and Intermediate-Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients: RV-MM-PI-0752 Phase III Randomized Study

Alessandra Larocca, MD, Marco Salvini, MD, Lorenzo De Paoli, MD, Nicola Cascavilla, MD, Giulia Benevolo, MD, Monica Galli, MD, Vittorio Montefusco, MD, Tommaso Caravita di Toritto, MD, Anna Baraldi, MD, Stefano Spada, Nicola Giuliani, MD PhD, Chiara Pautasso, Stefano Pulini, MD, Sonia Ronconi, MD, Norbert Pescosta, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Claudia Cellini, MD, Patrizia Tosi, MD, Massimo Offidani, MD, Michele Cavo, MD, Antonio Palumbo, MD, Mario Boccadoro, MD, Sara Bringhen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 305.
https://doi.org/10.1182/blood-2018-99-111796
Published: 2018
Journal Articles

Long Term Outcome of Lenalidomide-Dexamethasone (Rd) Vs Melphalan-Lenalidomide-Prednisone (MPR) Vs Cyclophosphamide-Prednisone-Lenalidomide (CPR) As Induction Followed By Lenalidomide-Prednisone (RP) Vs Lenalidomide (R) As Maintenance in a Community-Based Newly Diagnosed Myeloma Population: Updated Analysis of EMN01 Phase III Study

Sara Bringhen, MD, Massimo Offidani, MD, Pellegrino Musto, MD, Anna Marina Liberati, Giulia Benevolo, Nicola Cascavilla, MD, Mariella Genuardi, MD, Gianluca Gaidano, MD PhD, Donatella Zamagni, MD, Paola Ferrando, MD, Giovanni Pizzolo, Daniele Derudas, MD, Manuela Gambella, PhD, Alida Dominietto, MD, Ombretta Annibali, Giovanni Maria De Sabbata, MD, Attilio Gabbas, MD, Caterina Musolino, MD, Chiara Pautasso, Renato Zambello, MD, Giorgio La Nasa, MD, Laura Maracci, MD, Antonio Palumbo, MD, Roman Hájek, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 901.
https://doi.org/10.1182/blood.V130.Suppl_1.901.901
Published: 2017
Journal Articles

Prognostic Impact of Minimal Residual Disease By ASO-RQ-PCR in Multiple Myeloma: A Pooled Analysis of 2 Phase III Studies in Patients Treated with Lenalidomide after Front-Line Therapy

Stefania Oliva, MD, Manuela Gambella, Alessandra Larocca, Stefano Spada, Eleonora Marzanati, Barbara Mantoan, Sara Grammatico, Concetta Conticello, MD, Barbara Gamberi, Massimo Offidani, Anna Marina Liberati, Chiara Pautasso, Paola Omedé, Antonio Palumbo, MD, Mario Boccadoro
Journal: Blood
Blood (2016) 128 (22): 4409.
https://doi.org/10.1182/blood.V128.22.4409.4409
Published: 2016
Journal Articles

Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Sara Bringhen, Davide Rossi, MD, Maide Cavalli, MD, Roberto Ria, MD, Silvia Gentilini, MD, Francesca Patriarca, Chiara Nozzoli, MD, Anna Levi, MD, Tommasina Guglielmelli, MD, Giulia Benevolo, MD, Donatella Vincelli, MD, Luca Baldini, Fortunato Morabito, MD, Mariella Grasso, MD, Roberto Marasca, MD, Manuela Rizzo, MD, Chiara Pautasso, Pharm D, Antonietta Pia Falcone, MD, Daniela Gottardi, MD, Vittorio Montefusco, MD, Caterina Musolino, MD, Clotilde Cangialosi, MD, Giovanna Mansueto, MD, Anna Marina Liberati, MD, Valeria Magarotto, MD, Paola Omedè, PhD, Pellegrino Musto, MD, Maria Teresa Petrucci, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 200.
https://doi.org/10.1182/blood.V120.21.200.200
Published: 2012